U.S. Professional Services Stock News

Wondering whether Cleveland-Cliffs at a last close of US$8.11 offers value or a value trap? This breakdown will help you frame the price against what the business may be worth. The stock has recently shown mixed performance, with a 3.7% gain over the last 7 days but declines of 24.8% over 30 days, 40.4% year to date, and 4.8% over the past year. These moves sit against a longer track record that shows 55.8% and 58.2% declines over the past 3 and 5 years respectively. This can influence how...

Summit Therapeutics presented new Phase III data on ivonescimab at the 2026 European Lung Cancer Congress in EGFR mutated NSCLC. The data highlighted improved intracranial progression free survival, including in patients with brain metastases. The company has submitted a Biologics License Application to the FDA, with a PDUFA decision date set for November. Summit Therapeutics, trading as NasdaqGM:SMMT, is drawing attention after sharing these late stage results alongside a confirmed FDA...

Oklahoma Gas and Electric Company, a subsidiary of OGE Energy (NYSE:OGE), announced a new fixed-income offering of callable senior and subordinated unsecured fixed rate notes. The notes are structured as unsecured obligations and include both senior and subordinated tranches, with fixed interest rates. The securities are callable, meaning the issuer may choose to redeem them before maturity, subject to the offering terms. OGE Energy, through Oklahoma Gas and Electric, operates as a...

Some investors may be considering whether Grindr's current share price reflects its potential value, or whether the market is mispricing the stock at present. Over the past month, Grindr's share price has moved by 11.3%, while the 1 year return shows a 29.8% decline. This may draw the attention of investors who are weighing recent momentum against longer term performance. Recent coverage around Grindr has focused on its position as a listed interactive media and services platform, including...

If you are wondering whether Global-E Online is starting to look attractive or still carries too much risk, its recent share price moves and current valuation metrics give you plenty to think about. The stock last closed at US$28.93, with returns of a 10.5% decline over 7 days, a 17.6% decline over 30 days, a 23.6% decline year to date and an 18.9% decline over 1 year. These moves may have shifted how the market is pricing its prospects and risks. These moves have come as Global-E Online...

H.B. Fuller (NYSE:FUL) secured key raw materials after more than 40 force majeure notices linked to Middle East related supply disruptions. The company plans a minimum 10% global price increase effective April 1, 2026, to address inflation and raw material cost pressures. Management has paused acquisitions to focus on debt reduction and share buybacks, which signals a shift in capital allocation priorities. For investors watching NYSE:FUL, the share price sits at $59.17, with a 20.0% gain...

Revvity (NYSE:RVTY) plans to hold its annual meeting on April 28, 2026. Shareholders will vote on a proposed bylaw change to let holders of 25% of shares call special meetings. Activist-backed proposals seek tighter executive stock retention requirements tied to equity compensation. Revvity, which operates in life sciences and diagnostics, sits in a sector where governance practices are closely watched, partly because R&D cycles and regulatory oversight can shape capital allocation...

If you are wondering whether Cabot's current share price reflects its true worth, this article breaks down the key valuation clues you can use to judge it for yourself. Cabot recently closed at US$74.11, with returns of 9.3% over the past week, a 2.3% decline over the past month, 10.5% year to date and a 7.7% decline over the past year. Taken together, these figures give mixed signals about how the market is currently pricing the stock. Recent coverage around Cabot has focused on its...

Earlier this week, Gates Industrial Corporation, a manufacturer of engineered power transmission and fluid power solutions, was lifted by easing geopolitical tensions as postponed military action against Iran reduced perceived risk for globally exposed industrial companies. This shift in geopolitical risk sentiment matters for Gates because its end markets, including construction equipment and manufacturing, are closely tied to global economic stability and confidence in longer-term capital...

If you are wondering whether Ligand Pharmaceuticals at around US$195 a share still offers value, the next sections will walk through what the current price might be implying about the business. The stock has delivered an 81.6% return over 1 year and 165.7% over 3 years, while the shorter term picture shows a 4.6% decline over 7 days alongside modest gains of 2.1% over 30 days and 2.8% year to date. Recent coverage of Ligand Pharmaceuticals has focused on its role in the wider pharmaceuticals...

Sportradar Group (NasdaqGS:SRAD) has introduced Playradar, a new iGaming brand that combines live sports streaming with casino style gaming experiences. The company has also expanded its relationship with Hard Rock Bet to include official PGA TOUR and UFC data plus more advanced in play betting features. These updates extend Sportradar's role beyond core sports data into hybrid gaming products while deepening ties with a major US betting operator. Sportradar Group, trading at $17.15, is...

On March 16, 2026, at its Global Conference, XP Inc. drew attention as analysts highlighted a stronger-than-expected start to the year driven by heavier retail equity trading and anticipated client reimbursements from Brazil’s deposit insurance fund (FGC) flowing back into XP’s platform. The interesting angle for investors is how these FGC-related inflows, if reinvested into fixed-income products, could generate upfront commissions that temporarily enhance XP’s revenue mix and fee...

In recent commentary on Cullen/Frost Bankers, analysts highlighted that while Frost Bank’s prior quarterly results were solid, its revenue growth over the past two years has slowed relative to peers and its own five-year trend. An interesting takeaway is that consensus now points to a projected decline in tangible book value per share over the next 12 months, raising fresh questions about the bank’s capital generation and profitability outlook. Next, we’ll examine how slowing revenue growth...

Aptiv (NYSE:APTV) announced that Javed Khan, Executive Vice President and President of Intelligent Systems, is resigning to become CEO of a software and AI company. CEO Kevin Clark will take on Khan's responsibilities on an interim basis while Aptiv searches for a successor. Aptiv shares recently closed at $67.04, with the stock showing a 10.6% gain over the past year, a 14.5% decline year to date, and a 40.2% decline over three years. The Intelligent Systems segment is an important area...

If you are wondering whether Corpay's current share price reflects its underlying worth, you are not alone. This article focuses squarely on what you might be paying for each dollar of quality in the business. Corpay recently closed at US$284.93, with returns of a 0.9% decline over 7 days, a 13.7% decline over 30 days, a 5.2% decline year to date, a 17.8% decline over 1 year, alongside longer term returns of 35.1% over 3 years and 1.9% over 5 years. Recent coverage has highlighted Corpay in...

Wondering if Portland General Electric at around US$51.71 is offering fair value right now, or if the recent share price leaves something on the table for you? The stock is up 1.5% over the past week and 6.7% year to date, while the last 12 months show a 22.0% return despite a 3.3% pullback over the past month. Recent attention on regulated utilities and the broader power grid story has kept Portland General Electric in focus, as investors weigh the role of electricity providers in long term...

Monte Rosa Therapeutics (GLUE) has moved into focus after signing a supply agreement with Johnson & Johnson to evaluate MRT-2359 plus ERLEADA in a planned Phase 2 trial for metastatic castration-resistant prostate cancer. See our latest analysis for Monte Rosa Therapeutics. Alongside the Johnson & Johnson supply agreement and fresh MRT-2359 data, Monte Rosa’s share price has eased recently. The stock has a 30 day share price return of 15% and a 90 day share price return decline of 11%. At the...

Brookdale Senior Living (NYSE:BKD) has been recognized as a "Best Pet Workplace" by WUF World. The company is the first senior living provider to receive this designation. The award highlights Brookdale's focus on pet friendly policies for residents and associates. Brookdale Senior Living, trading at $13.82, now carries a "Best Pet Workplace" label that sets it apart within the senior living space. Over the past year, the stock has returned 124.7%, and it is up 27.5% year to date. This may...

Earlier in March, Campbell's reported fiscal Q2 2026 results showing lower net sales and EBIT, as storms in January disrupted shipments and lifted supply chain costs. These results come amid two years of falling unit sales and a projected 2.6% sales decline over the next 12 months, underscoring demand pressure in Campbell's core categories. Next, we’ll examine how weaker demand and weather-related supply chain disruptions might reshape Campbell's previously outlined investment...

Wondering whether WD-40 at around US$201 a share looks expensive, cheap, or somewhere in between? This article breaks down what the current price really represents. The stock is up 2.3% year to date, but that sits alongside a 5.9% decline over the last week, an 18.1% decline over the last month, and a 15.3% decline over the last year, which can change how investors think about both opportunity and risk. Recent coverage has focused on WD-40 as a long established brand in household products,...

Insiders who bought AstroNova, Inc. ( NASDAQ:ALOT ) stock in the last 12 months were richly rewarded last week. The...

On March 23, 2026, Piper Sandler Companies filed an amendment to its Delaware certificate of incorporation to complete a four-for-one forward stock split of its common stock, maintain the par value at US$0.01, increase authorized shares from 100,000,000 to 400,000,000, and begin split-adjusted trading on March 24 under a new CUSIP. This move materially increases the share count and lowers the price per share, which can broaden investor accessibility and enhance trading liquidity without...

Wondering whether McKesson at around US$860 a share still offers value or is pricing in most of its strengths already? This breakdown will help you frame that question clearly. The stock has seen a 2.9% decline over the last week and a 10.7% decline over the last month, although it still sits on a 4.5% return year to date and a 29.3% return over the past year. Recent coverage has focused on McKesson's role across healthcare distribution and services, as investors weigh how sector wide trends...

Millrose Properties (NYSE:MRP) has amended its credit facility, expanding it into a larger unsecured structure. The company is transitioning from a secured facility to an unsecured framework with added term loan capacity. This shift represents a material change in Millrose's capital structure and liquidity profile. For a real estate focused business like Millrose Properties, access to flexible credit can be just as important as the properties it owns. The move toward an unsecured facility...